MIC
JAZZ icon

Means Investment Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Means Investment Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,950
Closed -$248K – 210
2021
Q4 		$248K Sell
1,950
-350
-15% -$46K 0.04% 176
2021
Q3 		$299K Sell
2,300
-81
-3% -$12.2K 0.06% 148
2021
Q2 		$423K Sell
2,381
-3
-0.1% -$520 0.08% 126
2021
Q1 		$392K Sell
2,384
-20
-0.8% -$3.29K 0.09% 122
2020
Q4 		$401K Sell
2,404
-180
-7% -$26.8K 0.09% 117
2020
Q3 		$384K Sell
2,584
-70
-3% -$8.68K 0.11% 105
2020
Q2 		$326K Sell
2,654
-520
-16% -$57.5K 0.1% 104
2020
Q1 		$325K Hold
3,174
– – 0.13% 95
2019
Q4 		$479K Sell
3,174
-16
-0.5% -$2.18K 0.16% 83
2019
Q3 		$410K Buy
3,190
+650
+26% +$87.1K 0.15% 94
2019
Q2 		$362K Hold
2,540
– – 0.15% 97
2019
Q1 		$363K Sell
2,540
-225
-8% -$29.3K 0.16% 102
2018
Q4 		$343K Buy
+2,765
New +$410K 0.19% 92

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Means Investment Company's JAZZ Position: Q1 2022 in Review

Means Investment Company sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2022, closing a stake of 1,950 shares — an estimated $248K sold.

Means Investment Company first reported a position in JAZZ in Q4 2018 and held it in 13 quarters. The position peaked at $479K in Q4 2019. 461 funds tracked by Wall St. Rank hold JAZZ as of Q1 2022.

  • Means Investment Company reported no remaining Jazz Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Means Investment Company sold 1,950 Jazz Pharmaceuticals shares in Q1 2022, an estimated $248K.
  • Means Investment Company first reported a position in Jazz Pharmaceuticals in Q4 2018 and held it in 13 quarters.
  • Means Investment Company's Jazz Pharmaceuticals position peaked at $479K in Q4 2019.
  • 461 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2022.

Based on Means Investment Company's 13F filing for Q1 2022, filed 26 Apr 2022.